A diagnostic system designed for point-of-care use employs advanced acoustic technology and computational analysis to evaluate coronary blood flow, providing healthcare professionals with a patient-specific score indicating the risk of significant coronary artery disease (CAD). Key features include non-invasive assessments, high negative predictive value, and the ability to facilitate immediate risk stratification, ultimately aiding in the timely identification of patients who may require further evaluation, making it particularly beneficial for clinicians managing patients with chest pain or shortness of breath.
Acarix võib leida siit AI-powered Diagnosis & Healthcare Analytics kategooriad.
Ühtegi ekraanipilti pole veel üles laaditud. Kas see ettevõte kuulub teile?
Laadige üles ekraanipildid.A comprehensive pre-employment assessment platform evaluates candidates' skil...
A comprehensive platform for managing coronary artery disease (CAD) utilizes ...
This advanced imaging solution enhances cardiovascular diagnostics by providi...
This advanced diagnostic platform enhances cardiac care by providing healthca...
This innovative medical device enhances traditional auscultation by integrati...
The platform utilizes advanced artificial intelligence algorithms and robotic...
This advanced platform utilizes artificial intelligence to provide instant in...
This system offers a comprehensive platform for diagnosing, monitoring, and m...
Avastage selles kategoorias rohkem:
Iga päev lisandub uusi SaaS-tooteid, ainuüksi viimase 30 päeva jooksul on lisandunud 20,406. Püsige kursis ja olge esimesed, kes saavad teada, kui SaaS-brauser leiab teie otsingupäringule vastava uue SaaS-i.
Logi sisse, et seadistada meiliteated uute SaaS-ide jaoks, mis vastavad sinu otsingule.
Logi sisse teate loomiseks